glp-1 and muscle mass Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia Sarcopenic Obesity | Current Nutrition Reports How GLP-1 Helps Support Lean
Description
Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I736 amide in type I diabetic patients

Ozempic and Mounjaro are brand names used for those with diabetes

Endoplasmic reticulum (ER) stress is another critical etiology in the OA pathological process 9,10,11

Addressing Lifestyle Modifications: While GLP-1 drugs may offer a pharmaceutical approach to managing diabetes and obesity, the importance of holistic care involving lifestyle and dietary modifications will remain crucial
Reduced Caloric and Fiber Intake Patients on GLP-1 medications often eat significantly less food due to the medication's appetite-suppressing effects
They demonstrate that a murine model of diabetes is associated with the development of ER stress in beta cells
